| Year | Winner | Institution | Lecture |
|---|
| 2025 | Leen Antonio | KU Leuven | The Changing Landscape in the Assessment of Steroid Hormone concentrations: is it time to set them free? |
| 2024 | Jan Gunst | KU Leuven | Hyperglycemia and macronutrients: synergistically contributing to adverse outcome of critical illness? |
| 2023 | Philippe Lysy | UCL | The prismatic forms of diabetes in pediatrics: natural evolution, strategies for β-cell replacement, and tolerance to physical activity. |
| 2022 | Bruno Lapauw | UGhent | Determinants and consequences of sex steroid exposure in men. |
| 2021 | Katrien Benhalima | KU Leuven | Lessons from the Belgian Diabetes in Pregnancy study. |
| 2020 | Pieter Gillard | KU Leuven | Advanced therapies that improve glucose control and quality of life of people with type 1 diabetes. |
| 2019 | Liliya Rostomyan | ULiège | Pituitary gigantism: clinical characteristics and new insights into the genetics of GH-secreting pituitary adenomas. |
| 2018 | Iulia Potorac | ULiège | Mutations of the luteinizing hormone and its receptor – from phenotype to molecular anomalies. |
| 2017 | Patrice Cani | UCL | Gut microbiota, clinical implications in obesity and related metabolic disorders. |
| 2016 | Daniel A. Cunha | ULB | Saving private … beta-cells. |
| 2015 | Nico De Leu | VUB | VEGF and endothelial cells for beta cell protection, (re)generation and transplantation. |
| 2014 | Anne Simonne Parent | ULg | Early shaping and disorganization of the endocrine brain by environment. |
| 2012 | Ils Vanhorebeek | KUL | Multiple organ failure during critical illness: mitochondrial dysfunction and impaired autophagy as key targets for pharmacological intervention. |
| 2011 | Karolien De Bosscher | UGent | Molecular mechanisms modulating the glucocorticoid receptor. |
| 2010 | Myriam Cnop | ULB | Stress in the ER (endoplasmic reticulum) and the development of diabetes mellitus. |
| 2009 | Guy T'Sjoen | UGent | Presenting a state of the art lecture on endocrine care in treatment of transsexualism. |
| 2008 | Adrian F. Daly | ULg | The clinical, pathological, and genetic features of familial isolated pituitary adenomas. Eur J Endocrinol. 157:371-82, 2007. |
| 2007 | Kris Poppe | VUB | Thyroid autoimmunity and female infertility. Verh K Acad Geneeskd Belg. 2006;68:357-77. |
| 2006 | K. Spiegel | ULB | The endocrine and metabolic consequences of sleep loss. J Clin Endocrinol Metab. 2004 Nov;89(11):5762-71. |
| 2005 | C. Maenhaut | ULB | Profiles in gene expression in thyroid tumors and in model systems. Bull Mem Acad R Med Belg. 159:533-9; discussion 539-40, 2004. |
| 2004 | J.C. Jonas | UCL | Phenotypical alterations of pancreatic beta-cells exposed to supraphysiological glucose concentrations. Diabetologia. 46:1234-44, 2003. |
| 2003 | J.V. Swinnen | KUL | Androgens, lipogenesis and prostate cancer. Adv Exp Med Biol. 506: 379-87, 2002. |
| 2002 | H. Heimberg | VUB | Expansion and differentiation of exocrine cells from adult human pancreas towards endocrine β-cells by ectopic expression of key endocrinogenic transcription factors. Diabetes 50:2219-24, 2001. |
| 2001 | Chantal Mathieu | KUL | 1,25-dihydroxyvitamin D3: Endocrinology meets the immune system. Verh K Acad Geneeskd Belg. 64:71-80; 2002, discussion 80-2. |
| 2000 | P. Gilon | UCL | CA2+ signaling in the pancreatic B-cell: regulatory mechanisms and role in the control of insulin secretion. J Biol Chem. 16: 274(29):20197-205, 1999. |
| 1999 | I. Colin | UCL | Evidence for a role of vasoactive factors, endothelin-1 and nitric oxide, in thyroid specific angiogenic and inflammatory processes. Eur J Endocrinol. 136(6): 649-55, 1997. |
| 1998 | G. Van den Berghe | | Acute and prolonged critical illness as different neuroendocrine paradigms. J. Clin. Endocrinol. Metab. 83: 1827-1834, 1998. |
| 1997 | J. Parma | | Diversity and prevalence of somatic mutations in the TSH receptor and Gsα-genes as a cause of toxic thyroid adenomas. Clin. Endocrinol. Metab. 82: 2695-2701, 1997. |
| 1996 | F.E. de Zegher | | Small as foetus and short as child: from endogenous to exogenous growth hormone. J. Clin. Endocrinol. Metab. 82: 2021-2026, 1997. |
| 1994 | F.C. Schuit | | Factors determining the glucose sensitivity and glucose responsiveness of pancreatic β-cells. Horm. Res. 46: 99-106, 1996. |
| 1993 | M. Parmentier | | Orphan receptors: how many unknown messengers? |
| 1992 | J. Auwerx | | Regulation of gene expression by fatty acids and fibric acid derivatives: an integrative role for peroxisome proliferator activated receptors. Horm. Res. 38: 269-277, 1992. |
| 1991 | J.J. Body | | Calcitonin: from the determination of circulating levels in various physiological and pathological conditions, to the demonstration of lymphocyte receptors. Horm. Res. 39: 166-170, 1993. |
| 1990 | J. Verhaeghe | | The effect of diabetes mellitus on bone and mineral metabolism. Horm. Res. 34: 245-248, 1990. |
| 1989 | E. Van Cauter | | Diurnal and ultradian rhythms in human endocrine functions. Horm. Res. 34: 45-53, 1990. |
| 1988 | J.P. Bourguignon | | Time-related neuroendocrine manifestations of puberty. Horm. Res. 30: 224-234, 1988. |
| 1987 | R.J. Paridaens | | Characterization and therapeutic use of hormone dependence of breast cancer. Acta Clin. Belg. 43: 127-138, 1988. |
| 1986 | J.Cl. Henquin | | Regulation of insulin release by ionic and electrical events in β-cells. Horm. Res. 27: 168-178, 1987. |
| 1985 | D.G. Pipeleers | | Functional dissection of the endocrine pancreas. Horm. Res. 23: 225-234, 1986. |
